Terminalia albida treatment improves survival in experimental cerebral malaria through reactive oxygen species scavenging and anti-inflammatory properties
2019 · Malaria Journal · 34 citations
https://doi.org/10.1186/s12936-019-3071-9
K
Karine Reybier
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
76
Papers
2.2K
Citations
25
h-index
41
i10-index
Karine Reybier is an academic researcher from Université Fédérale de Toulouse Midi-Pyrénées. The author has contributed to research in topics: Malaria Research and Control & Mosquito-borne diseases and control & Research on Leishmaniasis Studies. The author has an h-index of 25, co-authored 65 publications.
ORCID: 0000-0002-3887-5414Papers by this author
worksRole of TRIM24 in the regulation of proteasome-autophagy crosstalk in bortezomib-resistant mantle cell lymphoma
2025 · Cell Death Discovery · 5 citations
https://doi.org/10.1038/s41420-025-02355-6
LUCS (Light-Up Cell System), a novel toxicity assay based on ROS and ABC transport status in live cell
2016 · HAL (Le Centre pour la Communication Scientifique Directe) · 0 citations
Modification and characterization of gold electrodes for cell trapping
2012 · HAL (Le Centre pour la Communication Scientifique Directe) · 0 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat